KEMENKES-NIH/NIAID INA-RESPOND – The Indonesia Research Partnership on Infectious Diseases

INA-RESPOND is a bilateral clinical research partnership between Indonesia and the United States,
represented by
the Directorate General of Advanced Health (Keslan), Ministry of Health of the Republic of Indonesia
and the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH),
advancing high quality, collaborative science in infectious diseases.

With a vision to minimize the impact of outbreaks and improve health in Indonesia, the United States, and globally,
INA-RESPOND connects a national network of hospitals, laboratories, and research institutions to generate evidence,
inform policy, and strengthen global health security.

About Us

About INA-RESPOND
Read More
Our Studies

INA-RESPOND's Our Studies
Read more
Latest Article

INA-RESPOND's latest article
Read more

INA-RESPOND at a GLIMPSE

COLLABORATORS

15 collaborators

STUDIES

12 multicenter studies, including observational and international clinical trials

HOSPITALS

19 hospitals across Indonesia, with potential collaboration within a CRU network under the Ministry of Health

PATHOGENS

Diagnostic coverage for 60+ pathogens

SPECIMENS

300.000+ research specimens managed

PUBLICATIONS

40 international scientific publications

About Us

Our Studies

Latest Article

INA-RESPOND Secretariat

Follow Us